Larvol Delta - AMLM26T5-INTERCEPT-A-multiarm-trial-for-patients-with-acute-myeloid-leukaemia-investigating-new-treatments-which-target-early-relapse-and-changes-in-disease-characteristics--MBG453-OR-MBG453-and-Azacitidine

sabatolimab (MBG453) - Novartis

azacitidine - Generic mfg.

https://anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=ACTRN12621001265864

Sep 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next